These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 8312051)

  • 1. Inhibition of entry of HIV into cells by poly(A).poly(U).
    Krust B; Callebaut C; Hovanessian AG
    AIDS Res Hum Retroviruses; 1993 Nov; 9(11):1087-90. PubMed ID: 8312051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiviral action of polyadenylic-polyuridylic acid against HIV in cell cultures.
    Laurent-Crawford AG; Krust B; Deschamps de Paillette E; Montagnier L; Hovanessian AG
    AIDS Res Hum Retroviruses; 1992 Feb; 8(2):285-90. PubMed ID: 1540414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dextran sulfate and other polyanionic anti-HIV compounds specifically interact with the viral gp120 glycoprotein expressed by T-cells persistently infected with HIV-1.
    Schols D; Pauwels R; Desmyter J; De Clercq E
    Virology; 1990 Apr; 175(2):556-61. PubMed ID: 1691563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single basic amino acid substitutions at position 302 or 320 in the V3 domain of HIV type 1 are not sufficient to alter the antiviral activity of dextran sulfate and heparin.
    Okada T; Gurney ME
    AIDS Res Hum Retroviruses; 1995 May; 11(5):571-5. PubMed ID: 7576913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sulphated polysaccharides exert anti-HIV activity at differing sites.
    Harrop HA; Rider CC; Coombe DR
    Biochem Soc Trans; 1992 May; 20(2):163S. PubMed ID: 1397551
    [No Abstract]   [Full Text] [Related]  

  • 6. Investigations into the mechanism by which sulfated polysaccharides inhibit HIV infection in vitro.
    McClure MO; Moore JP; Blanc DF; Scotting P; Cook GM; Keynes RJ; Weber JN; Davies D; Weiss RA
    AIDS Res Hum Retroviruses; 1992 Jan; 8(1):19-26. PubMed ID: 1346567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Are immunomodulators capable to improve the activity of nucleoside antiretroviral agents?].
    Sinet M; Pocidalo JJ
    Pathol Biol (Paris); 1993 Oct; 41(8 Pt 2):794-8. PubMed ID: 8309723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SPC3, a V3 loop-derived synthetic peptide inhibitor of HIV-1 infection, binds to cell surface glycosphingolipids.
    Delézay O; Hammache D; Fantini J; Yahi N
    Biochemistry; 1996 Dec; 35(49):15663-71. PubMed ID: 8961929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel, negatively charged, human serum albumins display potent and selective in vitro anti-human immunodeficiency virus type 1 activity.
    Jansen RW; Schols D; Pauwels R; De Clercq E; Meijer DK
    Mol Pharmacol; 1993 Nov; 44(5):1003-7. PubMed ID: 7902528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Additive effect of tunicamycin and dextran sulfate on the binding of monoclonal antibody to the V2 domain of the envelope glycoprotein 120 of human immunodeficiency virus type 1.
    Jagodzinski PP; Trzeciak WH
    Biomed Pharmacother; 2001 Jul; 55(6):308-12. PubMed ID: 11478581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of the V2, V3, and CD4-binding domains of GP120 in curdlan sulfate neutralization sensitivity of HIV-1 during infection of T lymphocytes.
    Jagodzinski PP; Wustner J; Kmieciak D; Wasik TJ; Fertala A; Sieron AL; Takahashi M; Tsuji T; Mimura T; Fung MS; Gorny MK; Kloczewiak M; Kaneko Y; Kozbor D
    Virology; 1996 Dec; 226(2):217-27. PubMed ID: 8955041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potent and specific inhibition of HIV envelope-mediated cell fusion and virus binding by G quartet-forming oligonucleotide (ISIS 5320).
    Buckheit RW; Roberson JL; Lackman-Smith C; Wyatt JR; Vickers TA; Ecker DJ
    AIDS Res Hum Retroviruses; 1994 Nov; 10(11):1497-506. PubMed ID: 7888204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Flavonoid baicalin inhibits HIV-1 infection at the level of viral entry.
    Li BQ; Fu T; Dongyan Y; Mikovits JA; Ruscetti FW; Wang JM
    Biochem Biophys Res Commun; 2000 Sep; 276(2):534-8. PubMed ID: 11027509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced human immunodeficiency virus infection in macrophages by high-molecular-weight dextran sulfate is associated with conformational changes of gp120 and expression of the CCR5 receptor.
    Jagodzinski PP; Wierzbicki A; Wustner J; Kaneko Y; Kozbor D
    Viral Immunol; 1999; 12(1):23-33. PubMed ID: 10333239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specific CD4 down-modulating compounds with potent anti-HIV activity.
    Vermeire K; Schols D
    J Leukoc Biol; 2003 Nov; 74(5):667-75. PubMed ID: 12960237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soluble gC1q-R/p33, a cell protein that binds to the globular "heads" of C1q, effectively inhibits the growth of HIV-1 strains in cell cultures.
    Szabó J; Cervenák L; Tóth FD; Prohászka Z; Horváth L; Kerekes K; Beck Z; Bácsi A; Erdei A; Peerschke EI; Füst G; Ghebrehiwet B
    Clin Immunol; 2001 May; 99(2):222-31. PubMed ID: 11318594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of host cell type and V3 loop of the surface glycoprotein on susceptibility of human immunodeficiency virus type 1 to polyanion compounds.
    Meylan PR; Kornbluth RS; Zbinden I; Richman DD
    Antimicrob Agents Chemother; 1994 Dec; 38(12):2910-6. PubMed ID: 7695283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The V3 region of gp120 is responsible for anti-HIV-1 activity of heparin sulphate.
    Jagodzinski PP; Trzeciak WH
    Acta Biochim Pol; 1998; 45(3):799-804. PubMed ID: 9918507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bathophenanthroline disulfonate and soluble CD4 as probes for early events of HIV type 1 entry.
    Demaria S; Tilley SA; Pinter A; Bushkin Y
    AIDS Res Hum Retroviruses; 1995 Jan; 11(1):127-39. PubMed ID: 7734186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiviral activity of magnesium and magnesium/poly r(A-U) combinations against two RNA viruses.
    Jamison J; Gilloteaux J; Nassiri MR; Tsai CC; Summers J
    Nucleosides Nucleotides; 1999; 18(6-7):1221-2. PubMed ID: 10474217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.